EX-32.1 5 v465720_ex32-1.htm EXHIBIT 32.1

Exhibit 32.1

AYTU BIOSCIENCE, INC.

Certification Pursuant to 18 U.S.C. Section 1350, as Adopted

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the filing of the quarterly report on Form 10-Q for the quarter ended March 31, 2017 (the “Report”) by Aytu BioScience, Inc. (the “Company”), each of the undersigned hereby certifies that:

| 1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and

| 2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: May 11, 2017 | /s/ Joshua R. Disbrow
| Joshua R. Disbrow
| Chief Executive Officer
Dated: May 11, 2017 | /s/ Gregory A. Gould
| Gregory A. Gould
| Chief Financial Officer